No insider purchase over the last 90 days. The latest, by ZIMMERMAN GIFFORD R, was filed 12 Nov 2020.
Nuveen Dow 30sm Dynamic Overwrite Fund is a Finance & Banking company. Its directors and officers file their transactions with SEC (Form 4). No insider at Nuveen Dow 30sm Dynamic Overwrite Fund has published a filing in the past twelve months. The most recent one dates from 30 November 2021.
The full history, which starts in 2017, counts 1 purchase against 2 sales.
In the same sector, recent insider purchases at Dynex Capital Inc and Presurance Holdings, Inc. also feature in our signals. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
3 of 3 declarations
Nuveen Dow 30℠ Dynamic Overwrite Fund (NYSE, United States) was a U.S.-listed closed-end fund designed to generate current income from large-cap U.S. equities through a dynamic overwrite, or covered-call, strategy. The fund belonged to Nuveen’s long-running closed-end fund platform and was positioned as an income-oriented equity vehicle rather than a pure capital appreciation product. In practical terms, DIAX combined exposure to a portfolio tied to the Dow Jones Industrial Average with the systematic sale of call options, allowing the fund to exchange part of its upside participation for option premium and potentially more regular distributions.
From a business-model standpoint, DIAX was not an operating company but an exchange-traded investment fund. That distinction matters for investors reading SEC Form 4 insider transaction filings, because ownership and governance structures differ materially from those of industrial or consumer companies. The fund’s underlying reference universe was the Dow 30, which means it was anchored in a basket of prominent blue-chip U.S. corporations across sectors such as financials, industrials, healthcare, technology, and consumer brands. For French, Belgian, and Swiss investors, that makes the fund an indirect and diversified gateway into the United States equity market, with a built-in income overlay.
Nuveen itself is one of the better-known names in income investing and alternatives. The firm states that it manages public and private assets globally and has a heritage of more than 125 years, with Chicago, Illinois as a core operating base. Within the closed-end fund space, Nuveen has been a major sponsor for decades, and DIAX sat alongside similar overwrite-oriented products such as SPXX and QQQX. Competitive positioning in this segment depends heavily on option implementation, portfolio discipline, and the sponsor’s brand credibility with income-focused investors. Compared with plain-vanilla index funds, overwrite funds offer a distinct risk-return profile: they may cushion some volatility through premium income, but they typically lag strongly rising markets because call option exposure caps part of the upside.
A key recent development is that DIAX was merged into the Nuveen S&P 500 Dynamic Overwrite Fund (SPXX). Nuveen announced that the merger of DIAX and another buy-write fund had been completed before the opening of the New York Stock Exchange on March 30, 2026. As a result, DIAX ceased to exist as a standalone listed fund after that date. For investors reviewing historical SEC filings, market data, or dividend history, this corporate action is material: it marks the end of DIAX as an independent NYSE-listed fund in the United States and explains why more recent activity may instead appear under SPXX or merger-related documentation.
Purchases our model currently ranks for the recommendations list.
All recommendations